2022_Oct_PODD_Boston_ Skyscraper2

PULMONARY & NASAL DRUG DELIVERY

Issue No #31  April 1st, 2012


Download PDF


CONTENTS
Achieving the Potential of Nasal Drug Delivery
Dr Shunji Haruta, Executive Officer, General Manager, NDS Division
SNBL Ltd
Technology Profile:
Aptar Pharma’s Twister Inhaler
Intranasal Vaccine Delivery – A Promising Future
Dr Tim Wolfe, Medical Adviser, LMA Atomization
Wolfe Tory Medical, Inc
Company Profile
teamtechnik Group
Conference Preview – Respiratory Drug Delivery (RDD) Conferences & Web Services
Dr Richard Dalby, Professor of Pharmaceutical Sciences
University of Maryland School of Pharmacy
Technology Profile
Aptar Pharma’s DF30Plus
Filling Dry-Powder Inhalers: a Paradigm Shift with Fill2Weight
Tom Bailey, Managing Director
Dr Dave Seaward, Projects Director
3P Innovation Ltd
Conference Review – Drug Delivery to the Lungs 22 (DDL 22)
Guy Furness, Publisher
ONdrugDelivery
Computational Modelling for Dry-Powder Inhalers
Ralf Kröger, Marc Horner & Robert Woolhouse
ANSYS Inc
Michael Becker & Herbert Wachtel
Boehringer Ingelheim Pharma GmbH & Co KG
Anne De Boer
University of Groningen
Company Profile
Phillips-Medisize
Top